Central Nervous System Diseases  >>  sagopilone (BAY86-5302)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sagopilone (BAY86-5302) / Bayer
NCT00496379: ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases

Terminated
2
15
US
ZK219477, ZK-EPO, ZK-Epothilone, Sagopilone
Nancy Lin, MD, Brigham and Women's Hospital, Bayer, Breast Cancer Research Foundation
Breast Cancer, CNS Disease
10/09
01/12

Download Options